Trial
NCT02593708
Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Michelle Melisko
Collaborators
—
Condition
Solid Tumor
Intervention
Neratinib
Why stopped
toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-17